ID   CARM1_HUMAN             Reviewed;         608 AA.
AC   Q86X55; A6NN38;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   28-JUN-2023, entry version 181.
DE   RecName: Full=Histone-arginine methyltransferase CARM1;
DE            EC=2.1.1.319 {ECO:0000269|PubMed:19405910};
DE   AltName: Full=Coactivator-associated arginine methyltransferase 1;
DE   AltName: Full=Protein arginine N-methyltransferase 4;
GN   Name=CARM1; Synonyms=PRMT4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE [MRNA] OF
RP   194-608 (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 43-608 (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   FUNCTION IN METHYLATION OF ELAVL1.
RX   PubMed=12237300; DOI=10.1074/jbc.m206187200;
RA   Li H., Park S., Kilburn B., Jelinek M.A., Henschen-Edman A., Aswad D.W.,
RA   Stallcup M.R., Laird-Offringa I.A.;
RT   "Lipopolysaccharide-induced methylation of HuR, an mRNA-stabilizing
RT   protein, by CARM1. Coactivator-associated arginine methyltransferase.";
RL   J. Biol. Chem. 277:44623-44630(2002).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15221992; DOI=10.1002/cncr.20327;
RA   Hong H., Kao C., Jeng M.-H., Eble J.N., Koch M.O., Gardner T.A., Zhang S.,
RA   Li L., Pan C.-X., Hu Z., MacLennan G.T., Cheng L.;
RT   "Aberrant expression of CARM1, a transcriptional coactivator of androgen
RT   receptor, in the development of prostate carcinoma and androgen-independent
RT   status.";
RL   Cancer 101:83-89(2004).
RN   [7]
RP   INTERACTION WITH NR1H4.
RX   PubMed=15471871; DOI=10.1074/jbc.m410021200;
RA   Ananthanarayanan M., Li S., Balasubramaniyan N., Suchy F.J., Walsh M.J.;
RT   "Ligand-dependent activation of the farnesoid X-receptor directs arginine
RT   methylation of histone H3 by CARM1.";
RL   J. Biol. Chem. 279:54348-54357(2004).
RN   [8]
RP   FUNCTION IN METHYLATION OF EP300.
RX   PubMed=15731352; DOI=10.1073/pnas.0407159102;
RA   Lee Y.-H., Coonrod S.A., Kraus W.L., Jelinek M.A., Stallcup M.R.;
RT   "Regulation of coactivator complex assembly and function by protein
RT   arginine methylation and demethylimination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:3611-3616(2005).
RN   [9]
RP   INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION).
RX   PubMed=17005681; DOI=10.1128/jvi.00186-06;
RA   Jeong S.J., Lu H., Cho W.K., Park H.U., Pise-Masison C., Brady J.N.;
RT   "Coactivator-associated arginine methyltransferase 1 enhances
RT   transcriptional activity of the human T-cell lymphotropic virus type 1 long
RT   terminal repeat through direct interaction with Tax.";
RL   J. Virol. 80:10036-10044(2006).
RN   [10]
RP   FUNCTION IN METHYLATION OF HISTONE H3, INTERACTION WITH RELA, AND FUNCTION.
RX   PubMed=16497732; DOI=10.1210/me.2005-0365;
RA   Miao F., Li S., Chavez V., Lanting L., Natarajan R.;
RT   "Coactivator-associated arginine methyltransferase-1 enhances nuclear
RT   factor-kappaB-mediated gene transcription through methylation of histone H3
RT   at arginine 17.";
RL   Mol. Endocrinol. 20:1562-1573(2006).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=19405910; DOI=10.1042/bj20090268;
RA   Lakowski T.M., Frankel A.;
RT   "Kinetic analysis of human protein arginine N-methyltransferase 2:
RT   formation of monomethyl- and asymmetric dimethyl-arginine residues on
RT   histone H4.";
RL   Biochem. J. 421:253-261(2009).
RN   [13]
RP   PHOSPHORYLATION AT SER-216, SUBCELLULAR LOCATION, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=19843527; DOI=10.1074/jbc.m109.065524;
RA   Feng Q., He B., Jung S.Y., Song Y., Qin J., Tsai S.Y., Tsai M.J.,
RA   O'Malley B.W.;
RT   "Biochemical control of CARM1 enzymatic activity by phosphorylation.";
RL   J. Biol. Chem. 284:36167-36174(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PARP1, AND MUTAGENESIS OF
RP   ARG-168.
RX   PubMed=33412112; DOI=10.1016/j.molcel.2020.12.010;
RA   Genois M.M., Gagne J.P., Yasuhara T., Jackson J., Saxena S.,
RA   Langelier M.F., Ahel I., Bedford M.T., Pascal J.M., Vindigni A.,
RA   Poirier G.G., Zou L.;
RT   "CARM1 regulates replication fork speed and stress response by stimulating
RT   PARP1.";
RL   Mol. Cell 81:784-800(2021).
RN   [17]
RP   UBIQUITINATION AT LYS-227, AND MUTAGENESIS OF LYS-227.
RX   PubMed=34480022; DOI=10.1038/s41419-021-04115-7;
RA   Lai Y., Li X., Li T., Nyunoya T., Chen K., Kitsios G.D., Nouraie S.M.,
RA   Zhang Y., McVerry B.J., Lee J.S., Mallampalli R.K., Zou C.;
RT   "Endotoxin stabilizes protein arginine methyltransferase 4 (PRMT4) protein
RT   triggering death of lung epithelia.";
RL   Cell Death Dis. 12:828-828(2021).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 135-482 IN COMPLEX WITH SAM ANALOG
RP   AND INHIBITORS, AND SAM BINDING SITES.
RX   PubMed=21410432; DOI=10.1042/bj20102161;
RA   Sack J.S., Thieffine S., Bandiera T., Fasolini M., Duke G.J., Jayaraman L.,
RA   Kish K.F., Klei H.E., Purandare A.V., Rosettani P., Troiani S., Xie D.,
RA   Bertrand J.A.;
RT   "Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.";
RL   Biochem. J. 436:331-339(2011).
CC   -!- FUNCTION: Methylates (mono- and asymmetric dimethylation) the guanidino
CC       nitrogens of arginyl residues in several proteins involved in DNA
CC       packaging, transcription regulation, pre-mRNA splicing, and mRNA
CC       stability (PubMed:12237300, PubMed:16497732, PubMed:19405910).
CC       Recruited to promoters upon gene activation together with histone
CC       acetyltransferases from EP300/P300 and p160 families, methylates
CC       histone H3 at 'Arg-17' (H3R17me), forming mainly asymmetric
CC       dimethylarginine (H3R17me2a), leading to activates transcription via
CC       chromatin remodeling (PubMed:12237300, PubMed:16497732,
CC       PubMed:19405910). During nuclear hormone receptor activation and
CC       TCF7L2/TCF4 activation, acts synergically with EP300/P300 and either
CC       one of the p160 histone acetyltransferases NCOA1/SRC1, NCOA2/GRIP1 and
CC       NCOA3/ACTR or CTNNB1/beta-catenin to activate transcription (By
CC       similarity). During myogenic transcriptional activation, acts together
CC       with NCOA3/ACTR as a coactivator for MEF2C (By similarity). During
CC       monocyte inflammatory stimulation, acts together with EP300/P300 as a
CC       coactivator for NF-kappa-B (By similarity). Acts as coactivator for
CC       PPARG, promotes adipocyte differentiation and the accumulation of brown
CC       fat tissue (By similarity). Plays a role in the regulation of pre-mRNA
CC       alternative splicing by methylation of splicing factors (By
CC       similarity). Also seems to be involved in p53/TP53 transcriptional
CC       activation (By similarity). Methylates EP300/P300, both at 'Arg-2142',
CC       which may loosen its interaction with NCOA2/GRIP1, and at 'Arg-580' and
CC       'Arg-604' in the KIX domain, which impairs its interaction with CREB
CC       and inhibits CREB-dependent transcriptional activation
CC       (PubMed:15731352). Also methylates arginine residues in RNA-binding
CC       proteins PABPC1, ELAVL1 and ELAV4, which may affect their mRNA-
CC       stabilizing properties and the half-life of their target mRNAs (By
CC       similarity). Acts as a transcriptional coactivator of ACACA/acetyl-CoA
CC       carboxylase by enriching H3R17 methylation at its promoter, thereby
CC       positively regulating fatty acid synthesis (By similarity).
CC       Independently of its methyltransferase activity, involved in
CC       replication fork progression: promotes PARP1 recruitment to replication
CC       forks, leading to poly-ADP-ribosylation of chromatin at replication
CC       forks and reduced fork speed (PubMed:33412112).
CC       {ECO:0000250|UniProtKB:Q9WVG6, ECO:0000269|PubMed:12237300,
CC       ECO:0000269|PubMed:15731352, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:19405910, ECO:0000269|PubMed:33412112}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-arginyl-[protein] + 2 S-adenosyl-L-methionine = 2 H(+) +
CC         N(omega),N(omega)-dimethyl-L-arginyl-[protein] + 2 S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:48096, Rhea:RHEA-COMP:10532, Rhea:RHEA-
CC         COMP:11991, ChEBI:CHEBI:15378, ChEBI:CHEBI:29965, ChEBI:CHEBI:57856,
CC         ChEBI:CHEBI:59789, ChEBI:CHEBI:61897; EC=2.1.1.319;
CC         Evidence={ECO:0000269|PubMed:19405910};
CC   -!- ACTIVITY REGULATION: Methylation of H3R17 (H3R17me) by CARM1 is
CC       stimulated by preacetylation of H3 'Lys-18' (H3K18ac) H3 'Lys-23'
CC       (H3K23ac) by EP300 and blocked by citrullination of H3 'Arg-17'
CC       (H3R17ci) by PADI4. {ECO:0000250|UniProtKB:Q9WVG6}.
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with NR1H4
CC       (PubMed:15471871). Interacts with SNRPC (By similarity). Interacts with
CC       the C-terminus of NCOA2/GRIP1, NCO3/ACTR and NCOA1/SRC1 (By
CC       similarity). Part of a complex consisting of CARM1, EP300/P300 and
CC       NCOA2/GRIP1 (By similarity). Interacts with FLII, TP53, myogenic factor
CC       MEF2, EP300/P300, TRIM24, CREBBP and CTNNB1 (By similarity). Interacts
CC       with RELA (PubMed:16497732). Identified in a complex containing CARM1,
CC       TRIM24 and NCOA2/GRIP1 (By similarity). Interacts with NCOA3/SRC3 (By
CC       similarity). Interacts with SKP2 (By similarity). Interacts (via PH
CC       domain-like fold) with C9orf72 (By similarity). Interacts with PARP1;
CC       promoting PARP1 recruimtent to replication forks (PubMed:33412112).
CC       {ECO:0000250|UniProtKB:Q4AE70, ECO:0000250|UniProtKB:Q9WVG6,
CC       ECO:0000269|PubMed:15471871, ECO:0000269|PubMed:16497732,
CC       ECO:0000269|PubMed:33412112}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HTLV-1 protein Tax.
CC       {ECO:0000269|PubMed:17005681}.
CC   -!- INTERACTION:
CC       Q86X55; P17676: CEBPB; NbExp=2; IntAct=EBI-2339854, EBI-969696;
CC       Q86X55; Q96EY1: DNAJA3; NbExp=2; IntAct=EBI-2339854, EBI-356767;
CC       Q86X55; Q6NYC1: JMJD6; NbExp=2; IntAct=EBI-2339854, EBI-8464037;
CC       Q86X55; Q9Y6Q9: NCOA3; NbExp=13; IntAct=EBI-2339854, EBI-81196;
CC       Q86X55; O43809: NUDT21; NbExp=2; IntAct=EBI-2339854, EBI-355720;
CC       Q86X55; Q96PU8: QKI; NbExp=2; IntAct=EBI-2339854, EBI-945792;
CC       Q86X55; Q92922: SMARCC1; NbExp=4; IntAct=EBI-2339854, EBI-355653;
CC       Q86X55; Q05826: CEBPB; Xeno; NbExp=3; IntAct=EBI-2339854, EBI-7774198;
CC       Q86X55; Q7ARE5: YPMT1.27c; Xeno; NbExp=2; IntAct=EBI-2339854, EBI-20592362;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19843527}. Cytoplasm
CC       {ECO:0000269|PubMed:19843527}. Chromosome
CC       {ECO:0000269|PubMed:33412112}. Note=Mainly nuclear during the G1, S and
CC       G2 phases of the cell cycle (PubMed:19843527). Cytoplasmic during
CC       mitosis, after breakup of the nuclear membrane (PubMed:19843527).
CC       Localizes to replication forks (PubMed:33412112).
CC       {ECO:0000269|PubMed:19843527, ECO:0000269|PubMed:33412112}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=Q86X55-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q86X55-1; Sequence=VSP_039876;
CC       Name=2;
CC         IsoId=Q86X55-2; Sequence=VSP_012506, VSP_012507;
CC   -!- TISSUE SPECIFICITY: Overexpressed in prostate adenocarcinomas and high-
CC       grade prostatic intraepithelial neoplasia.
CC       {ECO:0000269|PubMed:15221992}.
CC   -!- PTM: Auto-methylated on Arg-550. Methylation enhances transcription
CC       coactivator activity. Methylation is required for its role in the
CC       regulation of pre-mRNA alternative splicing (By similarity).
CC       {ECO:0000250|UniProtKB:Q9WVG6}.
CC   -!- PTM: Phosphorylation at Ser-216 is strongly increased during mitosis,
CC       and decreases rapidly to a very low, basal level after entry into the
CC       G1 phase of the cell cycle (PubMed:19843527). Phosphorylation at Ser-
CC       216 may promote location in the cytosol. Phosphorylation at Ser-216
CC       interferes with S-adenosyl-L-methionine binding and strongly reduces
CC       methyltransferase activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q9WVG6, ECO:0000269|PubMed:19843527}.
CC   -!- PTM: Ubiquitinated by E3 ubiquitin-protein ligase complex containing
CC       FBXO9 at Lys-227; leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:34480022}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. Protein arginine N-methyltransferase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01015}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC007565; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011442; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84156.1; -; Genomic_DNA.
DR   EMBL; BC046240; AAH46240.1; -; mRNA.
DR   EMBL; BC172490; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL833242; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS12250.1; -. [Q86X55-3]
DR   CCDS; CCDS92516.1; -. [Q86X55-1]
DR   RefSeq; NP_954592.1; NM_199141.1. [Q86X55-3]
DR   RefSeq; XP_005259765.1; XM_005259708.4.
DR   PDB; 2Y1W; X-ray; 2.10 A; A/B/C/D=135-482.
DR   PDB; 2Y1X; X-ray; 2.40 A; A/B/C/D=135-482.
DR   PDB; 4IKP; X-ray; 2.00 A; A/B/C/D=140-480.
DR   PDB; 5DWQ; X-ray; 2.36 A; A/B/C/D=134-479.
DR   PDB; 5DX0; X-ray; 2.05 A; A/B/C/D=134-479.
DR   PDB; 5DX1; X-ray; 1.93 A; A/B/C/D=134-479.
DR   PDB; 5DX8; X-ray; 1.94 A; A/B/C/D=134-479.
DR   PDB; 5DXA; X-ray; 2.07 A; A/B/C/D=134-479.
DR   PDB; 5DXJ; X-ray; 1.95 A; A/B/C/D=134-479.
DR   PDB; 5U4X; X-ray; 1.88 A; A/B/C/D=140-480.
DR   PDB; 6ARJ; X-ray; 1.92 A; A/B/C/D=134-479.
DR   PDB; 6ARV; X-ray; 2.00 A; A/B/C/D=134-479.
DR   PDB; 6D2L; X-ray; 2.00 A; A/B/C/D/E/F=146-489.
DR   PDB; 6DVR; X-ray; 1.54 A; A/B=146-489.
DR   PDB; 6IZQ; X-ray; 2.45 A; A/B/C/D=145-477.
DR   PDB; 6S70; X-ray; 2.30 A; A/B/C/D=135-479.
DR   PDB; 6S71; X-ray; 2.06 A; A/B/C/D=135-479.
DR   PDB; 6S74; X-ray; 2.10 A; A/B/C/D=135-479.
DR   PDB; 6S77; X-ray; 2.12 A; A/B/C/D=135-479.
DR   PDB; 6S79; X-ray; 2.10 A; A/B/C/D=135-479.
DR   PDB; 6S7A; X-ray; 1.86 A; A/B/C/D=135-479.
DR   PDB; 6S7B; X-ray; 2.66 A; A/B/C/D=135-479.
DR   PDB; 6S7C; X-ray; 2.30 A; A/B/C/D=135-479.
DR   PDB; 7FAI; X-ray; 2.10 A; A/B/C/D=142-477.
DR   PDB; 7FAJ; X-ray; 2.25 A; A/B/C/D=142-477.
DR   PDB; 7U9I; X-ray; 2.00 A; A/B=146-489.
DR   PDBsum; 2Y1W; -.
DR   PDBsum; 2Y1X; -.
DR   PDBsum; 4IKP; -.
DR   PDBsum; 5DWQ; -.
DR   PDBsum; 5DX0; -.
DR   PDBsum; 5DX1; -.
DR   PDBsum; 5DX8; -.
DR   PDBsum; 5DXA; -.
DR   PDBsum; 5DXJ; -.
DR   PDBsum; 5U4X; -.
DR   PDBsum; 6ARJ; -.
DR   PDBsum; 6ARV; -.
DR   PDBsum; 6D2L; -.
DR   PDBsum; 6DVR; -.
DR   PDBsum; 6IZQ; -.
DR   PDBsum; 6S70; -.
DR   PDBsum; 6S71; -.
DR   PDBsum; 6S74; -.
DR   PDBsum; 6S77; -.
DR   PDBsum; 6S79; -.
DR   PDBsum; 6S7A; -.
DR   PDBsum; 6S7B; -.
DR   PDBsum; 6S7C; -.
DR   PDBsum; 7FAI; -.
DR   PDBsum; 7FAJ; -.
DR   PDBsum; 7U9I; -.
DR   AlphaFoldDB; Q86X55; -.
DR   SMR; Q86X55; -.
DR   BioGRID; 115760; 332.
DR   CORUM; Q86X55; -.
DR   DIP; DIP-44071N; -.
DR   IntAct; Q86X55; 86.
DR   MINT; Q86X55; -.
DR   STRING; 9606.ENSP00000325690; -.
DR   BindingDB; Q86X55; -.
DR   ChEMBL; CHEMBL5406; -.
DR   GuidetoPHARMACOLOGY; 1255; -.
DR   GlyGen; Q86X55; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q86X55; -.
DR   PhosphoSitePlus; Q86X55; -.
DR   SwissPalm; Q86X55; -.
DR   BioMuta; CARM1; -.
DR   DMDM; 308153622; -.
DR   EPD; Q86X55; -.
DR   jPOST; Q86X55; -.
DR   MassIVE; Q86X55; -.
DR   MaxQB; Q86X55; -.
DR   PaxDb; Q86X55; -.
DR   PeptideAtlas; Q86X55; -.
DR   ProteomicsDB; 70241; -. [Q86X55-3]
DR   ProteomicsDB; 70242; -. [Q86X55-1]
DR   ProteomicsDB; 70243; -. [Q86X55-2]
DR   Antibodypedia; 25589; 703 antibodies from 40 providers.
DR   DNASU; 10498; -.
DR   Ensembl; ENST00000327064.9; ENSP00000325690.4; ENSG00000142453.12. [Q86X55-3]
DR   Ensembl; ENST00000344150.8; ENSP00000340934.3; ENSG00000142453.12. [Q86X55-1]
DR   GeneID; 10498; -.
DR   KEGG; hsa:10498; -.
DR   MANE-Select; ENST00000327064.9; ENSP00000325690.4; NM_199141.2; NP_954592.1.
DR   UCSC; uc002mpz.4; human. [Q86X55-3]
DR   AGR; HGNC:23393; -.
DR   CTD; 10498; -.
DR   DisGeNET; 10498; -.
DR   GeneCards; CARM1; -.
DR   HGNC; HGNC:23393; CARM1.
DR   HPA; ENSG00000142453; Tissue enhanced (skeletal).
DR   MIM; 603934; gene.
DR   neXtProt; NX_Q86X55; -.
DR   OpenTargets; ENSG00000142453; -.
DR   PharmGKB; PA134959553; -.
DR   VEuPathDB; HostDB:ENSG00000142453; -.
DR   eggNOG; KOG1500; Eukaryota.
DR   GeneTree; ENSGT00940000160377; -.
DR   HOGENOM; CLU_017375_0_1_1; -.
DR   InParanoid; Q86X55; -.
DR   OMA; AFWFDVL; -.
DR   OrthoDB; 197898at2759; -.
DR   PhylomeDB; Q86X55; -.
DR   TreeFam; TF323332; -.
DR   BioCyc; MetaCyc:HS13925-MON; -.
DR   BRENDA; 2.1.1.319; 2681.
DR   PathwayCommons; Q86X55; -.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by PPARalpha.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9707564; Cytoprotection by HMOX1.
DR   Reactome; R-HSA-9707616; Heme signaling.
DR   SignaLink; Q86X55; -.
DR   SIGNOR; Q86X55; -.
DR   BioGRID-ORCS; 10498; 166 hits in 1191 CRISPR screens.
DR   ChiTaRS; CARM1; human.
DR   GenomeRNAi; 10498; -.
DR   Pharos; Q86X55; Tchem.
DR   PRO; PR:Q86X55; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q86X55; protein.
DR   Bgee; ENSG00000142453; Expressed in hindlimb stylopod muscle and 191 other tissues.
DR   ExpressionAtlas; Q86X55; baseline and differential.
DR   Genevisible; Q86X55; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043596; C:nuclear replication fork; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; TAS:AgBase.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:GO_Central.
DR   GO; GO:0008469; F:histone arginine N-methyltransferase activity; IDA:CACAO.
DR   GO; GO:0035642; F:histone H3R17 methyltransferase activity; IDA:GO_Central.
DR   GO; GO:0070611; F:histone H3R2 methyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0042054; F:histone methyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; ISS:UniProtKB.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; ISS:UniProtKB.
DR   GO; GO:0008276; F:protein methyltransferase activity; IDA:UniProt.
DR   GO; GO:0016274; F:protein-arginine N-methyltransferase activity; IDA:MGI.
DR   GO; GO:0035242; F:protein-arginine omega-N asymmetric methyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:GO_Central.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0016571; P:histone methylation; ISS:UniProtKB.
DR   GO; GO:2000171; P:negative regulation of dendrite development; IEA:Ensembl.
DR   GO; GO:0018216; P:peptidyl-arginine methylation; IEA:InterPro.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:1904037; P:positive regulation of epithelial cell apoptotic process; IDA:UniProt.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; IDA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902415; P:regulation of mRNA binding; IEA:Ensembl.
DR   GO; GO:0071932; P:replication fork reversal; IDA:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   CDD; cd02440; AdoMet_MTases; 1.
DR   CDD; cd13330; PH_CARM1; 1.
DR   Gene3D; 2.70.160.11; Hnrnp arginine n-methyltransferase1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR025799; Arg_MeTrfase.
DR   InterPro; IPR020989; Histone-Arg_MeTrfase_N.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR11006:SF51; HISTONE-ARGININE METHYLTRANSFERASE CARM1; 1.
DR   PANTHER; PTHR11006; PROTEIN ARGININE N-METHYLTRANSFERASE; 1.
DR   Pfam; PF11531; CARM1; 1.
DR   Pfam; PF06325; PrmA; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   PROSITE; PS51678; SAM_MT_PRMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Chromosome; Cytoplasm; Host-virus interaction; Isopeptide bond;
KW   Methylation; Methyltransferase; Nucleus; Phosphoprotein;
KW   Reference proteome; S-adenosyl-L-methionine; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   CHAIN           2..608
FT                   /note="Histone-arginine methyltransferase CARM1"
FT                   /id="PRO_0000212338"
FT   DOMAIN          146..453
FT                   /note="SAM-dependent MTase PRMT-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01015"
FT   REGION          27..138
FT                   /note="Interaction with C9orf72"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   REGION          346..379
FT                   /note="Required for nuclear translocation"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   REGION          499..608
FT                   /note="Transactivation domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   BINDING         159
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:21410432"
FT   BINDING         168
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:21410432"
FT   BINDING         192
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:21410432"
FT   BINDING         214
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:21410432"
FT   BINDING         243
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:21410432"
FT   BINDING         271
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000305|PubMed:21410432"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19843527"
FT   MOD_RES         550
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WVG6"
FT   CROSSLNK        227
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000269|PubMed:34480022"
FT   VAR_SEQ         369..384
FT                   /note="RIEIPFKFHMLHSGLV -> SACLASPAATALCLPG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012506"
FT   VAR_SEQ         385..608
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_012507"
FT   VAR_SEQ         539..561
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_039876"
FT   MUTAGEN         168
FT                   /note="R->A: Loss of protein methyltransferase activity
FT                   without affecting ability to regulate replication fork
FT                   progression."
FT                   /evidence="ECO:0000269|PubMed:19405910"
FT   MUTAGEN         227
FT                   /note="K->A: Loss of FBXO9-mediated ubiquitination and
FT                   subsequent proteasomal degradation."
FT                   /evidence="ECO:0000269|PubMed:34480022"
FT   HELIX           136..140
FT                   /evidence="ECO:0007829|PDB:6S7A"
FT   HELIX           149..153
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           156..163
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           166..177
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           178..182
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   TURN            183..185
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          187..192
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           197..204
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          208..214
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           218..228
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   TURN            232..234
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          235..240
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   TURN            242..244
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          251..256
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   TURN            264..266
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           268..274
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           275..278
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          279..287
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          289..297
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           300..310
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           311..313
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           324..326
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           327..335
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          339..341
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           345..347
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          353..358
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   TURN            359..361
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   HELIX           364..368
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          369..380
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          382..396
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          401..405
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          417..428
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          433..443
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   TURN            444..446
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          447..456
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   TURN            457..459
FT                   /evidence="ECO:0007829|PDB:6DVR"
FT   STRAND          462..468
FT                   /evidence="ECO:0007829|PDB:6DVR"
SQ   SEQUENCE   608 AA;  65854 MW;  094AC60D4A70B263 CRC64;
     MAAAAAAVGP GAGGAGSAVP GGAGPCATVS VFPGARLLTI GDANGEIQRH AEQQALRLEV
     RAGPDSAGIA LYSHEDVCVF KCSVSRETEC SRVGKQSFII TLGCNSVLIQ FATPNDFCSF
     YNILKTCRGH TLERSVFSER TEESSAVQYF QFYGYLSQQQ NMMQDYVRTG TYQRAILQNH
     TDFKDKIVLD VGCGSGILSF FAAQAGARKI YAVEASTMAQ HAEVLVKSNN LTDRIVVIPG
     KVEEVSLPEQ VDIIISEPMG YMLFNERMLE SYLHAKKYLK PSGNMFPTIG DVHLAPFTDE
     QLYMEQFTKA NFWYQPSFHG VDLSALRGAA VDEYFRQPVV DTFDIRILMA KSVKYTVNFL
     EAKEGDLHRI EIPFKFHMLH SGLVHGLAFW FDVAFIGSIM TVWLSTAPTE PLTHWYQVRC
     LFQSPLFAKA GDTLSGTCLL IANKRQSYDI SIVAQVDQTG SKSSNLLDLK NPFFRYTGTT
     PSPPPGSHYT SPSENMWNTG STYNLSSGMA VAGMPTAYDL SSVIASGSSV GHNNLIPLAN
     TGIVNHTHSR MGSIMSTGIV QGSSGAQGSG GGSTSAHYAV NSQFTMGGPA ISMASPMSIP
     TNTMHYGS
//
